Intranasal midazolam as first‐line inhospital treatment for status epilepticus: a pharmaco‐EEG cohort study

OBJECTIVE: We sought to evaluate the efficacy and tolerability of intranasal midazolam (in‐MDZ) as first‐line inhospital therapy in patients with status epilepticus (SE) during continuous EEG recording. METHODS: Data on medical history, etiology and semiology of SE, anticonvulsive medication usage,...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Ann Clin Transl Neurol
Auteurs principaux: Kay, Lara, Merkel, Nina, von Blomberg, Anemone, Willems, Laurent M., Bauer, Sebastian, Reif, Philipp S., Schubert‐Bast, Susanne, Rosenow, Felix, Strzelczyk, Adam
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2019
Sujets:
Research Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6917318/
https://ncbi.nlm.nih.gov/pubmed/31682078
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.50932
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires